Your session is about to expire
← Back to Search
Study Summary
This trial will assess if a parent-child yoga program can reduce attention deficits in children with Congenital Heart Disease, to ultimately improve their long-term academic & psychosocial functioning & quality of life.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have a health condition that prevents me from doing yoga.My child needs special adaptations to participate in yoga due to a severe physical handicap.I am between 4 and 6 years old.My child struggles with attention and scored low on a specific attention test.I have been diagnosed with coronary heart disease needing surgery.I am willing to join an 8-week yoga program with my child and attend all assessments.My family does not speak French or English.I agree to stop my child's ADHD medication 48 hours before each assessment.Kids who have done yoga regularly for at least a month in the past year cannot join, but parents who have experience with yoga can participate.
- Group 1: Yoga group
- Group 2: Waitlist control group
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Can individuals over 35 years of age partake in this trial?
"According to the trial's entrance criteria, children aged between 4 and 6 can participate in this clinical study."
Who is eligible to participate in this medical research?
"The requirements for this trial are pediatric patients between the ages of 4 and 6 that have been diagnosed with a neurodevelopmental disorder. Up to 24 candidates will be accepted into the study."
Are there opportunities for new participants to join the trial?
"The study, listed on clinicaltrials.gov and initially posted on October 1st 2023, is still actively recruiting participants. It was last amended on August 11th 2023."
How many participants is this research endeavor accommodating?
"Affirmatively, according to clinicaltrials.gov this therapeutic experiment is recruiting participants. It was first initiated on October 1st 2023 and recently modified on August 11th 2023. A total of 24 subjects are needed from 2 disparate medical sites."
Share this study with friends
Copy Link
Messenger